ACE2 and COVID-19: Future analyses should aim to cover the prehospitalization period, to record all potentially relevant factors in the aldosterone–potassium relationship, and to generate evidence capable of directly weighing this ACE2 depletion theory against competing theories of renal potassium loss in COVID-19, like proximal tubular dysfunction and direct nucleocapsid-based activation of ENaC.